Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2016 - 2026)

Avanos Medical's Non-Current Deferred Tax Liability history spans 12 years, with the latest figure at $6.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 10.91% to $6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.1 million, a 10.91% increase, with the full-year FY2025 number at $6.1 million, up 10.91% from a year prior.
  • Non-Current Deferred Tax Liability hit $6.1 million in Q4 2025 for Avanos Medical, down from $6.3 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for AVNS hit a ceiling of $71.1 million in Q4 2022 and a floor of $5.5 million in Q4 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $22.7 million across 5 years, with a median of $22.6 million in 2023.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 560.71% in 2022 and later plummeted 92.22% in 2024.
  • Tracing AVNS's Non-Current Deferred Tax Liability over 5 years: stood at $11.9 million in 2021, then soared by 497.48% to $71.1 million in 2022, then decreased by 0.56% to $70.7 million in 2023, then plummeted by 92.22% to $5.5 million in 2024, then increased by 10.91% to $6.1 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for AVNS at $6.1 million in Q4 2025, $6.3 million in Q3 2025, and $6.3 million in Q2 2025.